BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25326018)

  • 1. Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6.
    Soleimani M; Jameie SB; Barati M; Mehdizadeh M; Kerdari M
    Iran Biomed J; 2014; 18(4):203-11. PubMed ID: 25326018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.
    Abdin AA; Hasby EA
    Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
    Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
    J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
    J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
    Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
    Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
    Clark MP; Leaman DW; Hazelhurst LA; Hwang ES; Quinn A
    Int Immunopharmacol; 2016 Feb; 31():74-87. PubMed ID: 26709219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis.
    Khakzad MR; Ganji A; Ariabod V; Farahani I
    Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):348-353. PubMed ID: 28952817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
    Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
    Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
    J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
    Haghmorad D; Amini AA; Mahmoudi MB; Rastin M; Hosseini M; Mahmoudi M
    J Neuroimmunol; 2014 Dec; 277(1-2):85-95. PubMed ID: 25457839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptide suppressed experimental autoimmune encephalomyelitis by inhibiting T helper 1 responses.
    Li H; Mei Y; Wang Y; Xu L
    J Clin Immunol; 2006 Sep; 26(5):430-7. PubMed ID: 16964563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
    Nath N; Giri S; Prasad R; Singh AK; Singh I
    J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Singh I; Singh AK
    Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Mao P; Manczak M; Shirendeb UP; Reddy PH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.